1. Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferon β-1a. (3rd October 2017) Authors: Frasco, Melissa A.; Shih, Tiffany; Incerti, Devin; Diaz Espinosa, Oliver; Vania, Diana K.; Thomas, Nina Journal: Journal of medical economics Issue: Volume 20:Number 10(2017) Page Start: 1074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗